₹25000
(Inclusive of all Taxes)
₹3750.0 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
Composition :
ADALIMUMAB-40MG
Manufacturer/Marketer :
Ipca Laboratories Ltd
Consume Type :
PARENTERAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Severe
Drug-Drug Interactions
Login/Sign Up
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
Using Adalipca 40 mg/0.8 ml Injection together with methylprednisolone may increase the risk of serious infections.
How to manage the interaction:
There may be a possibility of interaction between Methylprednisolone and Adalipca 40 mg/0.8 ml Injection, but it can be taken if prescribed by a doctor. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, consult a doctor. Do not stop using any medications without a doctor's advice.
Using Adalipca 40 mg/0.8 ml Injection together with methylprednisolone may increase the risk of serious infections.
How to manage the interaction:
There may be a possibility of interaction between Methylprednisolone and Adalipca 40 mg/0.8 ml Injection, but it can be taken if prescribed by a doctor. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, consult a doctor. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
Co-administration of Capecitabine is taken with Adalipca 40 mg/0.8 ml Injection, which may increase the risk or severity of infections.
How to manage the interaction:
There may be a possibility of interaction between Capecitabine and Adalipca 40 mg/0.8 ml Injection, but it can be taken if prescribed by a doctor. If you have any of these symptoms, it's important to contact a doctor right away. These symptoms include an enlarged spleen or liver, stomach pain, ongoing fever, excessive sweating at night, unexplained weight loss, complications, infection, fever, chills, diarrhea, a sore throat, muscle aches, difficulty breathing, or pain or discomfort while urinating. Do not stop using any medications without a doctor's advice.
Co-administration of Capecitabine is taken with Adalipca 40 mg/0.8 ml Injection, which may increase the risk or severity of infections.
How to manage the interaction:
There may be a possibility of interaction between Capecitabine and Adalipca 40 mg/0.8 ml Injection, but it can be taken if prescribed by a doctor. If you have any of these symptoms, it's important to contact a doctor right away. These symptoms include an enlarged spleen or liver, stomach pain, ongoing fever, excessive sweating at night, unexplained weight loss, complications, infection, fever, chills, diarrhea, a sore throat, muscle aches, difficulty breathing, or pain or discomfort while urinating. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
When Etoposide is used with Adalipca 40 mg/0.8 ml Injection, the likelihood or severity of infection may increase.
How to manage the interaction:
Although taking Etoposide and Adalipca 40 mg/0.8 ml Injection together can cause an interaction, it can be taken if a doctor has suggested it. However, if you develop fever, chills, diarrhea, sore throat, muscular pains, shortness of breath, blood in phlegm, weight loss, red or irritated skin, body sores, or discomfort or burning during urination, consult a doctor immediately. Do not discontinue any medications without a doctor's advice.
When Etoposide is used with Adalipca 40 mg/0.8 ml Injection, the likelihood or severity of infection may increase.
How to manage the interaction:
Although taking Etoposide and Adalipca 40 mg/0.8 ml Injection together can cause an interaction, it can be taken if a doctor has suggested it. However, if you develop fever, chills, diarrhea, sore throat, muscular pains, shortness of breath, blood in phlegm, weight loss, red or irritated skin, body sores, or discomfort or burning during urination, consult a doctor immediately. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
Combining Adalipca 40 mg/0.8 ml Injection with Deflazacort can increase the risk of severity of side effects.
How to manage the interaction:
Although there is a possibility of interaction between Deflazacort and Adalipca 40 mg/0.8 ml Injection, it can be taken if prescribed by a doctor. If you have any symptoms like fever, chills, diarrhea, a sore throat, muscle pain, or experiencing pain or burning when you urinate, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
Combining Adalipca 40 mg/0.8 ml Injection with Deflazacort can increase the risk of severity of side effects.
How to manage the interaction:
Although there is a possibility of interaction between Deflazacort and Adalipca 40 mg/0.8 ml Injection, it can be taken if prescribed by a doctor. If you have any symptoms like fever, chills, diarrhea, a sore throat, muscle pain, or experiencing pain or burning when you urinate, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
Co-administration of Adalipca 40 mg/0.8 ml Injection with Betamethasone can increase the risk of infections.
How to manage the interaction:
Co-administration of Betamethasone with Adalipca 40 mg/0.8 ml Injection can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: infection, complications, fever, chills, diarrhea, sore throat, muscle aches, trouble breathing, losing weight, or pain/burning when you pee. Do not discontinue any medications without consulting a doctor.
Co-administration of Adalipca 40 mg/0.8 ml Injection with Betamethasone can increase the risk of infections.
How to manage the interaction:
Co-administration of Betamethasone with Adalipca 40 mg/0.8 ml Injection can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: infection, complications, fever, chills, diarrhea, sore throat, muscle aches, trouble breathing, losing weight, or pain/burning when you pee. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
Using Adalipca 40 mg/0.8 ml Injection together with temozolomide may increase the risk of serious infections.
How to manage the interaction:
Although taking temozolomide and Adalipca 40 mg/0.8 ml Injection together can possibly result in an interaction, it can be taken if your doctor has prescribed it. However, consult the doctor immediately if you experience symptoms such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, red or inflamed skin, body sores, and pain or burning during urination. Do not stop using any medications without consulting doctor.
Using Adalipca 40 mg/0.8 ml Injection together with temozolomide may increase the risk of serious infections.
How to manage the interaction:
Although taking temozolomide and Adalipca 40 mg/0.8 ml Injection together can possibly result in an interaction, it can be taken if your doctor has prescribed it. However, consult the doctor immediately if you experience symptoms such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, red or inflamed skin, body sores, and pain or burning during urination. Do not stop using any medications without consulting doctor.
Severe
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
Taking Adalipca 40 mg/0.8 ml Injection with triamcinolone may increase the risk of infections.
How to manage the interaction:
Although there is an interaction between triamcinolone and Adalipca 40 mg/0.8 ml Injection, they can be taken together if prescribed by the doctor. Consult the doctor if you experience fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, weight loss, red or inflamed skin, body sores, and pain or burning during urination. Do not discontinue any medications without consulting a doctor.
Taking Adalipca 40 mg/0.8 ml Injection with triamcinolone may increase the risk of infections.
How to manage the interaction:
Although there is an interaction between triamcinolone and Adalipca 40 mg/0.8 ml Injection, they can be taken together if prescribed by the doctor. Consult the doctor if you experience fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, weight loss, red or inflamed skin, body sores, and pain or burning during urination. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
Combining Adalipca 40 mg/0.8 ml Injection with Carfilzomib can increase the risk of infections.
How to manage the interaction:
Co-administration of Carfilzomib with Adalipca 40 mg/0.8 ml Injection can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away infection, fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, weight loss, pain or burning during urination. Do not stop using any medications without first talking to your doctor.
Combining Adalipca 40 mg/0.8 ml Injection with Carfilzomib can increase the risk of infections.
How to manage the interaction:
Co-administration of Carfilzomib with Adalipca 40 mg/0.8 ml Injection can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away infection, fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, weight loss, pain or burning during urination. Do not stop using any medications without first talking to your doctor.
Severe
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
Taking Adalipca 40 mg/0.8 ml Injection with rituximab may increase the risk of infections.
How to manage the interaction:
Co-administration of Rituximab with Adalipca 40 mg/0.8 ml Injection can result in an interaction, but it can be taken if your doctor has advised it. However, consult the doctor immediately if you experience symptoms such as fever, chills, loose stools, sore throat, muscle aches, shortness of breath, red or inflamed skin, body sores, and pain or burning during urination. Do not stop using any medications without consulting a doctor.
Taking Adalipca 40 mg/0.8 ml Injection with rituximab may increase the risk of infections.
How to manage the interaction:
Co-administration of Rituximab with Adalipca 40 mg/0.8 ml Injection can result in an interaction, but it can be taken if your doctor has advised it. However, consult the doctor immediately if you experience symptoms such as fever, chills, loose stools, sore throat, muscle aches, shortness of breath, red or inflamed skin, body sores, and pain or burning during urination. Do not stop using any medications without consulting a doctor.
Severe
How does the drug interact with Adalipca 40 mg/0.8 ml Injection:
Combining Idarubicin and Adalipca 40 mg/0.8 ml Injection can increase the risk of developing serious infections.
How to manage the interaction:
Although there is an interaction, Idarubicin can be taken with Adalipca 40 mg/0.8 ml Injection if prescribed by the doctor. However, if you experience fever, chills, diarrhea, sore throat, muscle aches, breathing difficulty, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning when you urinate, consult a doctor. Do not discontinue any medications without a doctor's advice.
Combining Idarubicin and Adalipca 40 mg/0.8 ml Injection can increase the risk of developing serious infections.
How to manage the interaction:
Although there is an interaction, Idarubicin can be taken with Adalipca 40 mg/0.8 ml Injection if prescribed by the doctor. However, if you experience fever, chills, diarrhea, sore throat, muscle aches, breathing difficulty, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning when you urinate, consult a doctor. Do not discontinue any medications without a doctor's advice.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Adalipca 40 mg/0.8 ml Injection Substitute
Azimbra 40 mg Injection 0.4 ml
by Others
₹23280.00per tabletAdacord 40 mg Pfs Injection 0.8 ml
by Others
₹32220.00per tabletAdlumab 40mg Injection 0.8 ml
by Others
₹22545.90per tabletADMIRA 40MG/0.8ML INJECTION
by AYUR
₹21320.00per tabletCipleumab 40 mg Injection 1's
by Others
₹14760.00per tablet
Product Substitutes
Alcohol
Consult your doctor
It is not known if alcohol interacts with Adalipca 40 mg/0.8 ml Injection. Please consult the doctor.
Pregnancy
Caution
If you are pregnant or planning pregnancy, inform your doctor before receiving Adalipca 40 mg/0.8 ml Injection. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
If you are breastfeeding, inform your doctor before receiving Adalipca 40 mg/0.8 ml Injection.
Driving
Caution
Adalipca 40 mg/0.8 ml Injection will be administered in the hospital setting. Hence, driving is not recommended.
Liver
Caution
Adalipca 40 mg/0.8 ml Injection should be used with caution if you have liver disease. Dose adjustment may be needed in patients with liver impairment.
Kidney
Caution
Adalipca 40 mg/0.8 ml Injection should be used with caution if you have kidney disease. Dose adjustment may be needed in patients with liver impairment.
Children
Caution
Adalipca 40 mg/0.8 ml Injection is not recommended in children below two years of age as safety and efficacy are not established. In children above two years of age, it will be administered by the pediatrician. Adalipca 40 mg/0.8 ml Injection is used in children only for the treatment of juvenile idiopathic arthritis, paediatric Crohn’s disease, and uveitis.
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Keep Refrigerated. Do not freeze.Prepaid payment required.
Author Details
